CASP1 and PFAPA syndrome: In 2011 Pontillo et al. tried to find out a serological marker that could help discriminate monogenic AIDs from PFAPA syndrome: previous studies had described the human glycolytic enzyme α-enolase as a potential substrate of caspase-1, whose role in the activation of IL-1β through the inflammasome is nowadays well defined.